Claudin upregulation in ovarian carcinoma effusions is associated with poor survival
- 1 May 2008
- journal article
- Published by Elsevier in Human Pathology
- Vol. 39 (5), 747-757
- https://doi.org/10.1016/j.humpath.2007.10.002
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The Diagnostic Role of Claudins in Serous EffusionsAmerican Journal of Clinical Pathology, 2007
- Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal MesotheliomaClinical Cancer Research, 2006
- Crucial Roles of Sp1 and Epigenetic Modifications in the Regulation of the CLDN4 Promoter in Ovarian Cancer CellsJournal of Biological Chemistry, 2006
- Tight Junction Protein Claudin-1 Enhances the Invasive Activity of Oral Squamous Cell Carcinoma Cells by Promoting Cleavage of Laminin-5 γ2 Chain via Matrix Metalloproteinase (MMP)-2 and Membrane-Type MMP-1Cancer Research, 2006
- The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cellsBiochemical Journal, 2006
- Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic ProfilingClinical Cancer Research, 2006
- Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotypeThe Journal of Pathology, 2006
- CLAUDINS AND EPITHELIAL PARACELLULAR TRANSPORTAnnual Review of Physiology, 2006
- Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray studyLaboratory Investigation, 2005
- Tight junction proteinsProgress in Biophysics and Molecular Biology, 2002